Skip to main content
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Search
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Our ResearchOpen mainmenu item
    • Current topics from our research
    • Future Technologies
    • Energy and Climate
    • Health Innovation
    • Fundamentals of Nature
    • Large Research Facilities
    • Brochures
    • 5232 — The magazine of the Paul Scherrer Institute
    • Research Divisions & Labs (only english)
  • IndustryOpen mainmenu item
    • Overview
    • Technology Transfer
    • Expertise
    • Spin-off Companies
    • Park Innovaare
  • Proton TherapyOpen mainmenu item
    • Overview
    • Physician & Patient Information
  • CareerOpen mainmenu item
    • Overview
    • Job Opportunities
    • Working at PSI
    • Personnel Policy
    • Equal Opportunities, Diversity & Inclusion
    • Training and Further Education
    • Vocational Training
    • PSI Education Centre
    • Career Center
    • Support Program "PSI Career Return Program"
    • PSI-FELLOW/COFUND
  • Visit to PSIOpen mainmenu item
    • Overview
    • Visitor Centre psi forum
    • Schülerlabor iLab
    • Public Events
    • How to find us
  • About PSIOpen mainmenu item
    • PSI in brief
    • Strategy
    • Guiding principles
    • Facts and figures
    • Organisational structure
    • For the media
    • Suppliers and customers
    • Customers E-Billing
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

You are here:

  1. PSI Home
  2. Our Research
  3. Current topics from our research
  4. Health Innovation

Secondary navigation

Our Research

  • Current topics from our research Expanded submenu item
    • Future Technologies
    • Energy and Climate
    • Health Innovation
    • Fundamentals of Nature
    • ESI Platform
    • Large research facilities
    • Project SLS 2.0
    • Topic Overview
    • Archive
  • 5232 – The magazine of the Paul Scherrer Institute
    • Contact
  • Brochures
  • Films
    • Virtual Tour
  • Social Media
    • PSI Community Guidelines
  • Media corner
    • Media Releases

Health Innovation

In the area of Health Innovation, several research groups at PSI are engaged in the study of fundamental questions regarding biology and cancer therapy. For example, they explore the structure of proteins – extremely complex biomolecules that are responsible for many different functions in organisms. Using PSI’s large research facilities, scientists also explore processes in biological tissue in order to fully understand their function and the development of specific diseases or deterioration processes. The ultimate goal is to find medicines that allow people to live as healthy a life as possible.

Patients with specific types of cancer are treated at the proton therapy facility on the PSI campus. Radiopharmaceuticals provide cancer treatments for very small tumours distributed throughout the body.

Find out more at: Overview Health Innovation

18 October 2021
(Photo:Shutterstock.com/1051483496)

New active agent against parasites

Media Releases Research Using Synchrotron Light Biology Health Innovation Medical Science

PSI researchers identify potential active agent against several unicellular parasites – including the pathogens that cause malaria and toxoplasmosis.

Read more
28 September 2021
Roger Benoit

Protein distancing

Media Releases Biology Health Innovation

PSI researchers have developed a new method to attach proteins to the surface of virus-like particles.

Read more
23 September 2021
Diese 3-D-Grafik zeigt die SINQ, die zur Herstellung von Radionukliden für medizinische Zwecke dient.

Novel and emerging medical radionuclides

Media Releases Health Innovation Research Using Neutrons

Better treatment for disseminated cancer.

Read more
5 July 2021
Corona Dunkelziffer

Tracking down unreported Coronavirus cases

Research Using Synchrotron Light Biology Health Innovation Medical Science Research on Covid-19

The University Hospital of Zurich uses proteins made at PSI for Europe’s first large-scale serology study on coronavirus prevalence in Switzerland.

Read more
22 June 2021
 (Photo:Shutterstock.com)

PSI: advancing in the fight against Covid-19

Health Innovation Medical Science Research on Covid-19

Crystal structure analysis, computer models, cell cultures – to pursue research on Sars-CoV-2, PSI is exploring many avenues. An overview.

Read more
16 June 2021
Teaser Xavier Deupi

How immune cells are activated

Biology Health Innovation Medical Science

A research consortium has deciphered the mechanism of CCR5 receptor activation, providing insights for the development of CCR5 drug antagonists for AIDS, cancer, and inflammatory diseases.

Read more
11 May 2021
Teaser Remdesivir

How remdesivir works against the coronavirus

Health Innovation Medical Science Research on Covid-19

Researchers at Goethe University Frankfurt, in cooperation with the PSI have probably discovered another, previously unknown mechanism of action of the antiviral remdesivir.

Read more
6 May 2021
Teaser Tubulin

Cell cytoskeleton as target for new active agents

Media Releases Research Using Synchrotron Light Biology Health Innovation

Using a combination of computer simulations and laboratory experiments, PSI researchers have identified new binding sites for active agents on the vital protein tubulin.

Read more
2 March 2021
teaser

Watching receptor proteins changing shape

Research Using Synchrotron Light SwissFEL Biology Health Innovation

In our bodies, G protein-coupled receptors mediate countless processes. PSI researcher Ramon Guixà talks about how he brings those receptor molecules to life on the computer screen.

Read more
4 February 2021
teaser

"Ultimately, we aim to understand how diseases start in single cells"

Biology Health Innovation Medical Science Proton Therapy

Imaging and sequencing techniques combined with machine learning offer researchers countless opportunities to look inside cells with greater precision than ever before. G.V. Shivashankar, lab head at PSI, describes how such information can be used to find answers to pressing questions.

Read more
18 November 2020
Kaspar Dällenbach

Which particulate air pollution poses the greatest health risk?

Media Releases Energy and Climate Health Innovation Environment

The composition of particulate matter can influence its harmfulness to human health just as much as the amount, PSI researchers show in a newly published study. Experiments and computational modelling showed that in Europe high concentrations of particulate matter harmful to human health occur mainly in metropolitan areas.

Read more
19 October 2020
Teaser Proteinkristalle

Wait and see, and grow crystals

Research Using Synchrotron Light Biology Health Innovation Medical Science

At PSI, researchers decipher the structure of the proteins in bacteria and viruses. This knowledge can aid, for example, in the development of drugs against infectious diseases. But before the investigation can begin, an extremely tricky problem has to be solved: the crystallisation of the molecules.

Read more
14 October 2020
Doming

A protein's unexpected "doming"

Health Innovation Medical Science Radiopharmacy

Researchers have coaxed a secret out of the vital protein cytochrome c that it kept well-hidden up to now. Measurements at the X-ray free-electron laser SwissFEL reveal structural changes that science had previously ruled out for this kind of biomolecule.

Read more
5 October 2020
teaser

More effective treatment of thyroid cancer

Health Innovation Medical Science Radiopharmacy

PSI researchers have found a more effective treatment for a form of thyroid cancer – and with fewer side effects – by increasing the uptake of the cancer drug in tumour cells. The results have been published in the medical journal Theranostics.

Read more
30 September 2020
Teaser 5232 3/2020

Mites in the spotlight

Biology Health Innovation Medical Science

The world of microbes and viruses is extremely old and exceedingly diverse. With the large research facilities at PSI, researchers are peering deep inside this alien cosmos and investigating, above all, the proteins of these exotic beings.

Read more
28 September 2020
Serena Psoroulas mit der Versuchsanordnung in der Gantry 1

New technique for ultrafast tumour therapy

Media Releases Health Innovation Medical Science Proton Therapy

For the first time, researchers at the Centre for Proton Therapy at PSI have tested ultrafast, high-dose irradiation with protons. The new, experimental FLASH technique could revolutionise radiation therapy for cancer.

Read more
31 August 2020
May Sharpe

A question of binding

Research Using Synchrotron Light Large Research Facilities Biology Health Innovation Research on Covid-19

At PSI, researchers are screening molecule fragments to see if these bind to important proteins of the coronavirus SARS-CoV-2 and thus have the potential to disable it. They are hoping the many individual pieces of information will yield an answer as to what an effective drug might look like.

Read more
6 August 2020
Prevot

Coronavirus advice: Ventilate, ventilate, ventilate!

Biology Health Innovation Research on Covid-19

SARS-CoV-2 might be transmitted via aerosols, that is, through the air. Researchers point this out in the journal Clinical Infectious Diseases. André Prévôt from PSI co-signed the publication. In this interview, he explains which precautionary measures he recommends.

Read more
30 July 2020
Dr. May Elizabeth Sharpe

Covid-19 research: Anti-viral strategy with double effect

Research Using Synchrotron Light Biology Health Innovation Research on Covid-19

Frankfurt scientists identify a possible weakness of the SARS-CoV-2 virus. They carried out part of their measurements at PSI's Swiss Light Source SLS. The research results are published this week in the scientific journal Nature.

Read more
26 November 2019
Teaser Medikamente mit Strahlkraft

Brilliant medicines

Biology Health Innovation Radiopharmacy Medical Science

In the service of health, scientists at the Paul Scherrer Institute PSI work with radionuclides and develop agents to treat cancer and to detect tumours. Their research provides support to hospitals and is of great interest to Swiss industry.

Read more
  • First page « First
  • Previous page ‹‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next page ››
  • Last page Last »

Topic Overview

Sidebar

01/2023

5232 — The magazine of the Paul Scherrer Institute

01/2023
View in issuu.com
Download
Subscribe to our magazine

Follow PSI

 Twitter
 LinkedIn
 Youtube
 Facebook
 Instagram

All social media channels


Visitor Centre psi forum

Experience research live


The iLab School Laboratory

Experience Science - Explore Research

top

Footer

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Switzerland

Telephone: +41 56 310 21 11
Telefax: +41 56 310 21 99

How to find us
Contact

Visitor Centre psi forum
School Lab iLab (in German)
Center for Proton Therapy
PSI Education Centre
PSI Guest House
PSI Gastronomie (in German)
psi forum shop

Service & Support

  • Phone Book
  • User Office
  • Accelerator Status
  • PSI Publications
  • Suppliers
  • E-Billing
  • Computing
  • Safety (in German)

Career

  • Working at PSI
  • Job Opportunities
  • Training and further education
  • Career Center
  • Vocational Training (in German)
  • PSI Education Center

For the media

  • PSI in brief
  • Facts and Figures
  • Media corner
  • Media Releases
  • Social Media

Follow us: Twitter (in English) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Imprint
  • Terms and Conditions
  • Editors' login